Sinovac Biotech Ltd (SVA) — Cash Flow Reinvestment Rate
Sinovac Biotech Ltd (SVA) has a Cash Flow Reinvestment Rate of 0.36x as of December 2023, reinvesting $52.75 Million (capex $52.75 Million ) from operating cash flow of $146.01 Million. Explore SVA capital expenditure intensity to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Sinovac Biotech Ltd Cash Flow Reinvestment Rate (2007–2023)
Historical reinvestment intensity for Sinovac Biotech Ltd across 12 annual periods. Also explore Sinovac Biotech Ltd total assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Sinovac Biotech Ltd (2007–2023)
Year-by-year capital reinvestment analysis for Sinovac Biotech Ltd. For live market cap and broader valuation context, see SVA company net worth.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2023 | 28.96x | $3.07 Billion | $106.02 Million | $145.69 Million | ▲ +11774.8% |
| 2021 | 0.24x | $3.74 Billion | $15.35 Billion | $719.98 Million | ▼ -42.9% |
| 2020 | 0.43x | $204.78 Million | $479.31 Million | $127.65 Million | ▼ -68.6% |
| 2019 | 1.36x | $53.08 Million | $39.07 Million | $10.63 Million | ▼ -65.0% |
| 2018 | 3.89x | $30.87 Million | $7.94 Million | $5.61 Million | ▲ +875.5% |
| 2017 | 0.40x | $23.81 Million | $59.76 Million | $11.91 Million | ▼ -93.3% |
| 2015 | 5.93x | $24.97 Million | $4.21 Million | $5.30 Million | ▲ +544.1% |
| 2013 | 0.92x | $5.13 Million | $5.58 Million | $5.13 Million | ▼ -17.0% |
| 2011 | 1.11x | $15.46 Million | $13.94 Million | $15.46 Million | ▲ +1142.9% |
| 2009 | 0.09x | $4.32 Million | $48.41 Million | $4.32 Million | ▼ -76.4% |
| 2008 | 0.38x | $3.98 Million | $10.50 Million | $3.98 Million | ▼ -33.8% |
| 2007 | 0.57x | $2.47 Million | $4.32 Million | $2.47 Million | — |